Anlotinib Treatment in Steroid Depenent/Refractory cGVHD
Clinical trial NCT04232397 · TERMINATED
Trial details
- NCT number
- NCT04232397
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-10
- Primary completion
- 2020-09-15
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.